Prevention of N-methyl-d-aspartate-induced mechanical nociception by intrathecal administration of ketoprofen and ketamine in sheep

Anesthesia and Analgesia

Volumn 107, Issue 6, 2008, Pages 2061-2067

  Lizarraga, Ignacio ^a   Chambers, J Paul ^b   Johnson, Craig B ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; KETAMINE INJECTION; KETOPROFEN; N METHYL DEXTRO ASPARTIC ACID; SODIUM CHLORIDE; UNCLASSIFIED DRUG; XYLAZINE; N METHYLASPARTIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; XYLAN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HYPERALGESIA; HYPOALGESIA; INDWELLING CATHETER; MECHANICAL HYPERALGESIA; MECHANICAL HYPOALGESIA; MECHANICAL NOCICEPTION; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; SHEEP; ANIMAL; FEMALE; INTRASPINAL DRUG ADMINISTRATION; PAIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; INJECTIONS, SPINAL; KETAMINE; KETOPROFEN; N-METHYLASPARTATE; PAIN; SHEEP; XYLANS;

EID: 58149288023     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318187ac06     Document Type: Article

References (24)

1. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenaseprostanoid cascade in nociceptive processing. Ann Rev Pharmacol Toxicol 2002;42:553-83
2. Park YH, Shin CY, Lee TS, Hun IH, Sohn UD. The role of nitric oxide and PGE2 on the hyperalgesia induced by excitatory amino acids in rats. J Pharm Pharmacol 2000;52:431-6
3. Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC. The acute antihyperalgesic action of nonsteroidal, antiinflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001;21: 5847-53
4. Dolan S, Nolan AM. N-methyl-d-aspartate induced mechanical allodynia is blocked by nitric oxide synthase and cyclooxygenase-2 inhibitors. Neuroreport 1999;10:449-52
5. Hawksworth C, Serpell M. Intrathecal anesthesia with ketamine. Reg Anesth Pain Med 1998;23:283-8
6. Stotz M, Oehen H-P, Gerber H. Histological findings after long-term infusion of intrathecal ketamine for chronic pain: a case report. J Pain Symptom Manage 1999;18:223-8
7. Devoghel JC. Small intrathecal doses of lysine-acetylsalicylate relieve intractable pain in man. J Int Med Res 1983;11:90-1
8. Vranken JH, Troost D, Wegener JT, Kruis MR, van der Vegt MH. Neuropathological findings after continuous intrathecal administration of S(-)-ketamine for the management of neuropathic cancer pain. Pain 2005;117:231-5
9. Lizarraga I, Chambers JP, Johnson CB. Synergistic depression of NMDA receptor-mediated segmental transmission by ketamine, ketoprofen, and l-NAME combinations in neonatal rat spinal cords in vitro. Br J Pharmacol 2008;153:1030-42
10. Kyles AE, Waterman A, Livingston A. Chronic intrathecal catheterization in sheep. J Pharmacol Toxicol Methods 1992;27: 177-83
11. Lizarraga I, Chambers JP. Involvement of opiodergic and -2- adrenergic mechanisms in the central analgesic effects of nonsteroidal anti-inflammatory drugs in sheep. Res Vet Sci 2006;80:194-200
12. Hassenbusch SJ, Satterfield WC, Gradert TL, Binhazim AW, Ahad G, Mokhtarzadeh M, Schapiro SJ, Payne R. Preclinical toxicity study of intrathecal administration of the pain relievers dextrorphan, dextromethorphan, and memantine in the sheep model. Neuromodulation 1999;2:230-40
13. Waterman A, Livingston A, Bouchenafa O. Analgesic effects of intrathecally applied 2-adrenoceptor agonists in conscious, unrestrained sheep. Neuropharmacology 1988;27:213-6
14. Lizarraga I, Chambers JP, Johnson CB. Depression of NMDAreceptor- mediated segmental transmission by ketamine and ketoprofen, but not l-NAME, on the in vitro neonatal rat spinal cord preparation. Brain Res 2006;1094:57-64
15. Waterman A, Livingston A. Studies on the distribution and metabolism of ketamine in sheep. J Vet Pharmacol Ther 1978;1:141-7
16. Kyles AE, Waterman AE, Livingston A. The spinal antinociceptive activity of the 2-adrenoceptor agonist, xylazine in sheep. Br J Pharmacol 1993;108:907-13
17. Hocking G, Wildsmith JAW. Intrathecal drug spread. Br J Anaesth 2004;93:568-78
18. Yaksh TL Spinal analgesic mechanisms. In: Justins DM, ed. Pain 2005-An updated review. Refresher course syllabus. Seattle: IASP Press, 2005:369-80
19. Chambers JP. The influence of chronic pain on the action of analgesic drugs. PhD Thesis. Bristol, UK: University of Bristol, 1992
20. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999;96:7563-8
21. Sprenger T, Valet M, Woltmann R, Zimmer C, Freynhagen R, Kochs EF, Tö lle TR, Wagner KJ. Imaging pain modulation by subanesthetic S-(-)-ketamine. Anesth Analg 2006;103:729-37
22. Tallarida RJ. Drug synergism and dose-effect data analysis. Boca Raton: Chapman & Hall/CRC, 2000
23. Pelissier T, Infante C, Constandil L, Espinosa J, Lapeyra CD, Herna'ndez A. Antinociceptive effect and interaction of uncompetitive and competitive NMDA receptor antagonists upon capsaicin and paw pressure testing in normal and monoarthritic rats. Pain 2008;134:113-27
24. Welsh EM, Nolan AM. The effect of abdominal surgery on thresholds to thermal and mechanical stimulation in sheep. Pain 1995;60:159-66